NEW YORK (GenomeWeb News) – Gen-Probe is targeting a 2011 launch in the US for its molecular diagnostic assay for human papillomavirus, CFO Herm Rosenman told investors Wednesday afternoon at the UBS Global Life Sciences Conference.

The San Diego-based firm received the CE Mark and launched the Aptima HPV Assay in Europe in May. The test runs on its Tigris instrument system, which Rosenman said is the only fully automated molecular diagnostics instrument on the market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.